Welcome
Support Centre
21 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Safety and efficacy of procainamide and amiodarone in the treatment of atrial fibrillation of recent onset
ISRCTN ISRCTN28131679
ClinicalTrials.gov identifier
Public title Safety and efficacy of procainamide and amiodarone in the treatment of atrial fibrillation of recent onset
Scientific title
Acronym N/A
Serial number at source N/A
Study hypothesis To study whether procainamide and amiodarone are both effective after digoxin administration to restore sinus rhythm
Lay summary
Ethics approval Approved by the University
of Athens on 4/5/1998, reference number 78/1998
Study design Randomised double-blind controlled trial
Countries of recruitment Greece
Disease/condition/study domain Atrial fibrillation
Participants - inclusion criteria Atrial fibrillation of recent onset (less than 24 hours)
Participants - exclusion criteria 1. Age <18 years
2. Baseline systolic blood pressure <100 mmHg
3. Known thyroid disease
4. Serum potassium <3.5 mmol/l
5. Pre-treatment with any anti-arrhythmic drug
6. Documented permanent AF, atrial flutter and a corrected heart rate (QTc) interval >440 msec
Anticipated start date 05/05/1998
Anticipated end date 20/08/2003
Status of trial Completed
Patient information material
Target number of participants 225
Interventions After administration of digitalis (digoxin), and in case of failure to restore Sinus Rhythm (SR), the patients were randomized into two groups. Randomization was performed with the use of sealed envelopes, thus guaranteeing an almost equal number of patients.
Group A (113 patients) received amiodarone intravenously 300 mg in 30 minutes and in case of failure to restore SR, amiodarone was continued for a further 24 hours as an intravenous infusion (maintenance) of 20 mg/kg.
Group B (110 patients) were administered a bolus dose of 1 g intravenous procainamide, and in the case of failure to restore sinus rhythm in 30 minutes, 2 mg/min (maintenance) for the next 24 hours. The other two participants decided to be treated privately, therefore both received digitalis and the study medication, but did not stay in the NHS long enough to be included in the study.
Primary outcome measure(s) Restoration of sinus rhythm
Secondary outcome measure(s) 1. Time of cardioversion
2. Blood pressure fluctuations
Sources of funding Greek National Health Service (Greece)
Trial website
Publications 2007 results in http://www.ncbi.nlm.nih.gov/pubmed/17653020
Contact name Dr  Theodoros  Xanthos
  Address 15B Agiou Thoma street
  City/town Athens
  Zip/Postcode 11527
  Country Greece
  Email theodorosxanthos@yahoo.com
Sponsor Greek National Health Service (Greece)
  Address 15B Agiou Thoma street
  City/town Athens
  Zip/Postcode 11527
  Country Greece
  Tel +30 (0) 2106972221
  Email lilapapadimitriou@hotmail.com
Date applied 23/02/2006
Last edited 25/09/2009
Date ISRCTN assigned 08/03/2006
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central